Cocaine overtakes heroin as leading cause of drug deaths in England and Wales

In 2025, cocaine was implicated in more than one in five drug poisoning deaths registered across England and Wales, making it the single substance most frequently cited in these tragic incidents. This figure represents a significant escalation, with charities and experts attributing the rise to a confluence of factors, including increased purity and greater availability of the illicit stimulant on the streets. The ONS data reveals that cocaine was mentioned in 1,233 cases, a slight decrease from the previous year but still exceeding the 1,210 deaths linked to heroin or morphine. This latter figure also represents a fall from its prior year’s level, further highlighting the ascendancy of cocaine.

Beyond the headline shift between cocaine and heroin, the ONS report also illuminated other concerning trends. Notably, a record 115 deaths were registered as being linked to ketamine, a figure that has almost doubled since 2024. This substantial increase in ketamine-related fatalities adds another layer of complexity to the drug death landscape, suggesting a diversification in the types of substances contributing to mortality. While the overall rate of drug deaths in England and Wales saw a decline for the first time since 2012, falling to 92.4 deaths per million people from 93.9 per million a year earlier, this reduction is overshadowed by persistent and growing regional inequalities.

The data starkly illustrates a widening disparity in drug death rates across the country. The rate of such deaths in the North East of England was more than twice as high as in London, a statistic that points to significant socio-economic and public health variations that may be exacerbating the problem in certain areas. This geographical divide suggests that while national efforts to combat drug deaths may be yielding some overall positive results, they are not reaching all communities equally, and localized interventions may be falling short.

The total number of drug poisoning deaths registered in England and Wales in 2025 stood at 5,519. While this represents a decrease from the previous year, it remains a profoundly high number, reflecting the ongoing impact of drug misuse on individuals, families, and communities. The ONS emphasizes that there is a lag between drug-related deaths occurring and their subsequent registration, meaning the true picture of mortality may be even more severe than the reported figures indicate. This temporal delay can complicate immediate public health responses and the accurate assessment of intervention effectiveness.

It is crucial to note that while cocaine has emerged as the single leading cause of drug poisoning deaths, deaths linked to opiates and opioids combined still represent a higher overall burden. These classes of drugs, including heroin and prescription painkillers, have historically been major contributors to drug fatalities, and their continued prevalence underscores the multifaceted nature of the drug crisis. The ONS acknowledges this distinction, clarifying that the shift in the headline figure reflects the leading single substance rather than the totality of opioid-related deaths.

The ONS data for England and Wales contrasts with trends observed in other parts of the United Kingdom. In September, National Records of Scotland reported an 11% rise in drug deaths in 2025, maintaining Scotland’s position as having the worst mortality rate from drug misuse in Europe. This highlights a persistent and deeply entrenched problem north of the border, which has resisted national efforts to curb the epidemic. Similarly, in May, the Northern Ireland Statistics and Research Agency indicated that drug-related deaths in Northern Ireland rose by 7.1% between the 2021-23 and 2022-24 periods. These figures from Scotland and Northern Ireland underscore that while England and Wales may be experiencing a shift in the primary substances involved, the broader challenge of drug-related mortality remains a critical issue across the entire UK, with each nation facing its own unique set of contributing factors and escalating crises.

The rise in cocaine-related deaths, coupled with the surge in ketamine fatalities and persistent opioid issues, points to a complex and evolving drug market. Factors such as increased drug purity, which means users may be consuming more potent substances without realizing it, and greater accessibility due to organized crime networks, are frequently cited as key drivers. The perceived glamour and social acceptance of cocaine use in certain circles may also contribute to its widespread adoption and subsequent fatalities. The ONS data serves as a stark reminder that drug use remains a significant public health emergency, requiring sustained and adaptive strategies to prevent loss of life and address the underlying causes of addiction and drug dependency.

The growing regional inequalities in drug death rates also necessitate targeted interventions. Understanding why areas like the North East are disproportionately affected is critical. This could involve examining localized socio-economic factors, the availability of harm reduction services, patterns of drug supply, and the accessibility of treatment and support for individuals struggling with addiction. A "one-size-fits-all" approach to drug policy is clearly insufficient when faced with such stark regional disparities.

The ONS’s acknowledgement of the lag between death occurrence and registration is also a vital point. This means that the reported figures for 2025 are based on deaths that may have occurred in earlier periods. A more timely reporting mechanism would allow for quicker identification of emerging trends and more agile responses from public health bodies.

In conclusion, the shift in drug death statistics in England and Wales, with cocaine now leading the grim tally, is a wake-up call. It signals the urgent need for a comprehensive re-evaluation of drug policy, prevention strategies, and treatment services. The increasing purity and availability of cocaine, alongside the concerning rise in ketamine deaths and the persistent threat of opioids, demand a multi-pronged approach that addresses supply reduction, demand reduction, harm reduction, and robust support for those affected by addiction. The widening regional disparities further emphasize the need for tailored, localized solutions to ensure that no community is left behind in the fight against drug-related mortality.